Literature DB >> 11160198

CTLA4Ig-induced linked regulation of allogeneic T cell responses.

R S Lee1, J R Rusche, M E Maloney, D H Sachs, M H Sayegh, J C Madsen.   

Abstract

The mechanisms by which CTLA4Ig exerts its powerful immunomodulatory effects are not clear. We show here that CTLA4Ig can induce linked regulation of allogeneic porcine T cell responses in vitro. Naive miniature swine SLA(dd) T cells were rendered hyporesponsive to specific allogeneic Ag after coculturing with MHC-mismatched SLA(cc) stimulators in the presence of CTLA4Ig. These Ag-specific hyporesponsive T cells were subsequently able to actively inhibit the allogeneic responses of naive syngeneic T cells in an MHC-linked fashion, as the responses of naive SLA(dd) responders against specific SLA(cc) and (SLA(ac))F(1) stimulators were inhibited, but allogeneic responses against a 1:1 mixture of SLA(aa) (I(a), II(a)) and SLA(cc) (I(c), II(c)) were maintained. This inhibition could be generated against either class I or class II Ags, was radiosensitive, and required cell-cell contact. Furthermore, the mechanism of inhibition was not dependent upon a deletional, apoptotic pathway, but it was reversed by anti-IL-10 mAb. These data suggest that CTLA4Ig-induced inhibition of naive allogeneic T cell responses can be mediated through the generation of regulatory T cells via an IL-10-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160198     DOI: 10.4049/jimmunol.166.3.1572

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.

Authors:  R S Lee; K Yamada; S L Houser; K L Womer; M E Maloney; H S Rose; M H Sayegh; J C Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  Immune intervention in type 1 diabetes.

Authors:  Aaron W Michels; George S Eisenbarth
Journal:  Semin Immunol       Date:  2011-08-17       Impact factor: 11.130

3.  A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.

Authors:  Andrea Vergani; Francesca D'Addio; Mollie Jurewicz; Alessandra Petrelli; Toshihiko Watanabe; Kaifeng Liu; Kenneth Law; Christian Schuetz; Michele Carvello; Elena Orsenigo; Shaoping Deng; Scott J Rodig; Javeed M Ansari; Carlo Staudacher; Reza Abdi; John Williams; James Markmann; Mark Atkinson; Mohamed H Sayegh; Paolo Fiorina
Journal:  Diabetes       Date:  2010-09       Impact factor: 9.461

4.  GITR Blockade Facilitates Treg Mediated Allograft Survival.

Authors:  Samsher B Sonawane; James I Kim; Major K Lee; Seoung-Hoon Lee; Patrick E Duff; Daniel J Moore; Moh-Moh Lian; Shaoping Deng; Yongwon Choi; Heidi Yeh; Andrew J Caton; James F Markmann
Journal:  Transplantation       Date:  2009-11-27       Impact factor: 4.939

5.  Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.

Authors:  William van der Touw; Paolo Cravedi; Wing-hong Kwan; Estela Paz-Artal; Miriam Merad; Peter S Heeger
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

6.  The effects of tolerance on allograft damage caused by the innate immune system.

Authors:  Ruediger Hoerbelt; Christopher L Benjamin; Tsuyoshi Shoji; Stuart L Houser; Ashok Muniappan; Rebecca S Hasse; Levi G Ledgerwood; James S Allan; David H Sachs; Joren C Madsen
Journal:  Transplantation       Date:  2008-02-15       Impact factor: 4.939

7.  Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.

Authors:  Weiyun Shi; Min Chen; Lixin Xie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-31       Impact factor: 3.117

8.  IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.

Authors:  Robert Sucher; Klaus Fischler; Rupert Oberhuber; Irmgard Kronberger; Christian Margreiter; Robert Ollinger; Stefan Schneeberger; Dietmar Fuchs; Ernst R Werner; Katrin Watschinger; Bettina Zelger; George Tellides; Nina Pilat; Johann Pratschke; Raimund Margreiter; Thomas Wekerle; Gerald Brandacher
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

9.  Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Authors:  Vanessa Oliveira; Birgit Sawitzki; Stephanie Chapman; Christine Appelt; Inga Gebuhr; Joanna Wieckiewicz; Elaine Long; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

Review 10.  Immunosuppression for lung transplantation.

Authors:  Choo Y Ng; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.